Black Rock Inc. Verve Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,620,004 shares of VERV stock, worth $73.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,620,004

Previous 5,373,177 23.2%

Holding current value

$73.7 Million

Previous $71.4 Million 54.73%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.76 - $12.79 $5.93 Million - $15.9 Million	1,246,827 Added 23.2%	6,620,004 $32.3 Million
Q1 2024 May 10, 2024	BUY	$10.81 - $17.96 $10.1 Million - $16.8 Million	937,696 Added 21.14%	5,373,177 $71.4 Million
Q4 2023 Feb 13, 2024	BUY	$8.84 - $18.7 $3.86 Million - $8.17 Million	437,082 Added 10.93%	4,435,481 $61.8 Million
Q3 2023 Nov 13, 2023	BUY	$11.42 - $20.82 $1.73 Million - $3.16 Million	151,696 Added 3.94%	3,998,399 $53 Million
Q2 2023 Aug 11, 2023	BUY	$13.34 - $19.9 $4 Million - $5.97 Million	300,218 Added 8.47%	3,846,703 $72.1 Million

Q1 2023 May 12, 2023	SELL	$14.3 - $24.01 $680,522 - $1.14 Million	-47,589 Reduced 1.32%	3,546,485 $51.1 Million
Q4 2022 Feb 13, 2023	BUY	$17.85 - $40.7 $3.89 Million - $8.87 Million	217,864 Added 6.45%	3,594,074 $69.5 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $12.4 Million - $32.9 Million	792,139 Added 30.65%	3,376,210 $116 Million
Q2 2022 Aug 12, 2022	BUY	$11.14 - $23.17 $4.74 Million - $9.86 Million	425,509 Added 19.71%	2,584,071 $39.5 Million
Q1 2022 May 12, 2022	BUY	$20.92 - $39.36 $19.1 Million - $36 Million	915,090 Added 73.59%	2,158,562 $49.3 Million
Q4 2021 Feb 10, 2022	BUY	$31.94 - $54.82 $9.55 Million - $16.4 Million	299,015 Added 31.66%	1,243,472 $45.8 Million
Q3 2021 Nov 09, 2021	BUY	$46.0 - $73.99 $19.1 Million - $30.7 Million	414,533 Added 78.22%	944,457 $44.4 Million
Q2 2021 Aug 11, 2021	BUY	$31.92 - $60.25 $16.9 Million - $31.9 Million	529,924 New	529,924 $31.9 Million

Others Institutions Holding VERV

# of Institutions

Shares Held

8.52M

Call Options Held

2.9K

Put Options Held

37.1K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $667M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account